Table 3.
Selected pregnancy outcomes in HIV-infected women according to protease inhibitor use.
| ART with a protease inhibitor | ART without a protease inhibitor | No ART | p value | |
|---|---|---|---|---|
| n = 597 | n = 230 | n = 177 | ||
| Gestational age at delivery, weeks | 38.0 ± 2.3 | 38.5 ± 2.2 | 37.8 ± 3.0 | 0.003 |
| Preterm birth <37 weeks | 82 (14) | 31 (13) | 37 (21) | 0.049∗ |
| Preterm birth <34 weeks | 26 (4) | 11 (5) | 18 (10) | 0.01∗ |
| Birth weight, grams | 3010 ± 607 | 3080 ± 657 | 2904 ± 686 | 0.02 |
| SGA | 116 (19) | 54 (23) | 39 (22) | 0.4 |
Data reported as mean ± SD, median (quartiles), or n (%) as appropriate.
SGA: small-for-gestational-age defined as less than 10th percentile for gestational age.
∗ p values demonstrate a significance between women who did not receive ART and the other two groups.